Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytruda® in Advanced Pancreatic Cancer
Stock Information for Oncolytics Biotech Inc.
Loading
Please wait while we load your information from QuoteMedia.